Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Louis W Sullivan is Director at United Therapeutics. OQRO lists 33 transactions filed with the SEC under this name, the latest on Jul 24, 2026, each linked to the official Form 4.
Director
Disclosures on record
33
Companies involved
1
As of the latest filing on , Louis W Sullivan reported holding 2,983 shares of United Therapeutics (UTHR), worth about $1.65M at the last close of $555 (Nov 20, 2026). In the last 12 months, Louis W Sullivan sold $3.05M in 2 sales.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| United Therapeutics UTHR | 2,983 | 2,983 direct | $555 | $1.65M | Jul 9, 2026 |
Is this Louis W Sullivan’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
United TherapeuticsUTHR
33 disclosures · Dec 2024 – Jul 2026 · 26 sold
Jul 22, 20262,380disclosed Jul 24
DetailsOfficial recordJul 9, 2026650disclosed Jul 14
DetailsJul 9, 2026650disclosed Jul 14
DetailsOfficial recordDec 22, 2025Sold~$2.49Mdisclosed Dec 24
DetailsOfficial recordDec 22, 2025Sold~$556Kdisclosed Dec 24
DetailsOfficial recordDec 22, 20252,720disclosed Dec 24
DetailsOfficial recordDec 22, 20253,230disclosed Dec 24
DetailsOfficial recordDec 22, 20253,230disclosed Dec 24
DetailsOfficial recordDec 22, 20252,720disclosed Dec 24
DetailsOfficial recordDec 18, 2024Sold~$1.01Mdisclosed Dec 19
DetailsOfficial recordDec 18, 2024Sold~$917Kdisclosed Dec 19
DetailsOfficial recordDec 18, 2024Sold~$825Kdisclosed Dec 19
DetailsOfficial recordDec 18, 2024Sold~$776Kdisclosed Dec 19
DetailsOfficial recordDec 18, 2024Sold~$734Kdisclosed Dec 19
DetailsOfficial recordDec 18, 2024Sold~$713Kdisclosed Dec 19
DetailsOfficial recordDec 18, 2024Sold~$569Kdisclosed Dec 19
DetailsOfficial recordDec 18, 2024Sold~$560Kdisclosed Dec 19
DetailsOfficial recordDec 18, 2024Sold~$518Kdisclosed Dec 19
DetailsOfficial recordDec 18, 2024Sold~$482Kdisclosed Dec 19
DetailsOfficial recordDec 18, 2024Sold~$410Kdisclosed Dec 19
DetailsOfficial recordDec 18, 2024Sold~$358Kdisclosed Dec 19
DetailsOfficial recordDec 18, 2024Sold~$305Kdisclosed Dec 19
DetailsOfficial recordDec 18, 2024Sold~$277Kdisclosed Dec 19
DetailsOfficial recordDec 18, 2024Sold~$266Kdisclosed Dec 19
DetailsOfficial recordDec 18, 2024Sold~$236Kdisclosed Dec 19
DetailsOfficial recordDec 18, 2024Sold~$220Kdisclosed Dec 19
DetailsOfficial recordDec 18, 2024Sold~$187Kdisclosed Dec 19
DetailsOfficial recordDec 18, 2024Sold~$151Kdisclosed Dec 19
DetailsOfficial recordDec 18, 2024Sold~$74Kdisclosed Dec 19
DetailsOfficial recordDec 18, 2024Sold~$76Kdisclosed Dec 19
DetailsOfficial recordDec 18, 2024Sold~$38Kdisclosed Dec 19
DetailsOfficial recordDec 18, 2024Sold~$38Kdisclosed Dec 19
DetailsOfficial recordDec 18, 2024Sold~$37Kdisclosed Dec 19
DetailsOfficial recordLouis W Sullivan bought shares on the open market in 2011, and has not bought since 2011 across 4 companies. Sales in each of the last 4 years.
Louis W Sullivan reported 2 open-market purchases and 76 sales since 2007; purchases in 2011.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | $3.05M2×2 trades |
| 2024 | — | $11.1M26×26 trades |
| 2023 | — | $548K3×3 trades |
| 2022 | — | $3.04M8×8 trades |
| 2020 | — | $3.63M3×3 trades |
| 2016 | — | $5.27M9×9 trades |
| 2015 | — | $5.61M8×8 trades |
| 2014 | — | $5.31M6×6 trades |
| 2013 | — | $4.85M2×2 trades |
| 2011 | $44K2×2 trades | $2.47M4×4 trades |
| 2010 | — | $1.64M4×4 trades |
| 2007 | — | $2.13M1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Jul 9, 2026, Louis W Sullivan reported holding 2,983 shares of United Therapeutics (UTHR). At the last close of $555 on Nov 20, 2026, that is about $1.65M. This is the stake disclosed in filings, not a net worth.
No public filing gives Louis W Sullivan's net worth. What SEC Form 4 shows is the stock stake: 2,983 shares of United Therapeutics (UTHR), about $1.65M at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
In SEC filings of the last 12 months, Louis W Sullivan reported 2 open-market sales worth $3.05M, and no open-market purchase. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Louis W Sullivan bought shares on the open market in 2011, and has not bought since 2011 across 4 companies. Sales in each of the last 4 years.
In SEC filings since 2007: the latest open-market purchase is from 2011; the latest open-market sale is from 2025.
4 companies: United Therapeutics (UTHR, 2007–2025), Emergent Biosolutions (EBS, 2015–2020), Henry Schein (HSIC, 2011–2016), ANI Pharmaceuticals, Inc. (ANIP, 2011).
Louis W Sullivan reported 0 open-market purchases and 51 sales here, 2007 to 2025.
Louis W Sullivan reported 0 open-market purchases and 14 sales here, 2011 to 2016.
Louis W Sullivan reported 0 open-market purchases and 11 sales here, 2015 to 2020.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.